All In Biotech

Drug Trial Radar · NCT07292012

Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease

Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease : EMINENT-CD

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

75

Planned (sponsor's estimate)

Start

May 11, 2026

Primary completion

Nov 2027

Study completion Nov 2028

Sponsor

Sponsor type
Academic, hospital or other
First posted
Dec 18, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Supportive care
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Efficacy of Mirikizumab to achieve transmural healing in patients with Crohn's Disease

Conditions

  • Crohn Disease (CD)

Interventions

  • Mirikizumab - IVDrug

    Mirikizumab induction with IV infusions (900 mg) at week 0, week 4 and week 8.

  • Mirikizumab - SCDrug

    SC injections (300 mg) at W12 and every 4 weeks For clinical responders and non-responders

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Transmural response (TR25)Time frame: From week 0 to week 24

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • CHU de Brest - Hôpital de la Cavale Blanche

    Brest, France · Recruiting

  • CHU Caen Normandie

    Caen, France · Not yet recruiting

  • CHU de Clermont Ferrand - Hôpital d'Estaing

    Clermont-Ferrand, France · Recruiting

  • CHU de Nîmes Carémeau

    Nîmes, France · Recruiting

  • Institut Mutualiste Monsouris

    Paris, France · Active not recruiting

  • CHU Poitiers

    Poitiers, France · Not yet recruiting

  • CHU de Toulouse - Hôpital Rangueil

    Toulouse, France · Recruiting

  • CH de Valence

    Valence, France · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.